NEW YORK, June 1 (GenomeWeb News) - Aclara Biosciences and ViroLogic have signed a merger agreement to create a molecular diagnostics company for oncology and infectious diseases, the companies said today. The new company will be called ViroLogic.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.